Researchers have identified two brain receptors that help the brain clear away amyloid beta, a hallmark of Alzheimer’s ...

Late last year, Health Canada approved lecanemab, a monoclonal antibody that clears amyloid plaques — a hallmark indicator of Alzheimer’s disease — in people with early-stage dementia while symptoms ...

Korsana’s lead program uses a next-generation shuttling technology to improve delivery into the brain and lower the incidence of amyloid-related imaging abnormalities.

Findings could streamline enrollment for Alzheimer's clinical trials ...

Engaging in mentally stimulating activities throughout life can build cognitive reserve, potentially delaying the onset of ...

A new entrant in the race to shepherd antibodies for Alzheimer’s disease across the blood-brain barrier has emerged. | A new entrant in the race to shepherd antibodies for Alzheimer’s disease across ...

A new light-based imaging approach has produced an unprecedented chemical map of the Alzheimer’s brain. Rice University researchers have produced what they describe as the first full, label-free ...

A single protein in your blood can rise for years before Alzheimer’s symptoms appear. In a new study, researchers argue that ...

Researchers show that in mice, tumor-secreted cystatin-C crosses the blood–brain barrier and stimulates microglia to degrade ...

Immunoprecipitation-enhanced blood-based biomarkers are improving early diagnosis of Alzheimer’s disease by enabling more ...

It has the potential to predict symptom onset so accurately "we could use it in individual clinical care,” said one ...